Neurogene (NGNE) PT Raised to $77 at Leerink

July 1, 2026 2:38 PM

Leerink analyst Mani Foroohar raised the price target on Neurogene (NASDAQ: NGNE) to $77.00 (from $70.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found